Vaccination campaign in Africa aims to protect 50M people against meningitis

NewsGuard 100/100 Score

"A huge vaccination campaign to protect 50 million people against meningitis has been launched in seven African countries aiming to stamp out the deadly virus, health officials said on Thursday," Sapa/AFP/IOL News reports. "The so-called 'Meningitis Belt' countries -- Benin, Cameroon, Chad, Ghana, Nigeria, Senegal, and Sudan -- are to get the jabs to ensure 'a dramatic impact across the continent,' said Seth Berkley, managing director of the GAVI Alliance," according to the news service (10/4). "The seven countries targeted are vulnerable to seasonal severe outbreaks of meningitis with up to 430 million people at risk from the illness, according to a news release issued by the GAVI Alliance," the U.N. News Centre writes, noting, "The vaccination drive will ensure those at high risk, particularly children and young adults, are vaccinated by the end of December" (10/4).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    New dry powder aerosol COVID-19 vaccine shows promise against multiple virus strains